Vireo Growth Inc. Announces Launch of Adult-Use Cannabis Sales in Minnesota
Vireo Growth (OTCQX: VREOF) has launched adult-use cannabis sales across all eight Green Goods® dispensaries in Minnesota, marking a significant expansion from its existing medical cannabis operations. The company, which has served Minnesota's medical market since 2014, made its first adult-use sale on September 16, 2025, in downtown Minneapolis.
With Minnesota's population of 5.7 million, Vireo expects strong organic revenue growth from this market expansion. The company offers a comprehensive product line including flower, pre-rolls, edibles, and beverages across locations in Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester, and Woodbury.
Vireo Growth (OTCQX: VREOF) ha lanciato la vendita di cannabis per uso adulto in tutti gli otto dispensari Green Goods® in Minnesota, segnando una significativa espansione rispetto alle operazioni mediche esistenti. L'azienda, che serve il mercato medico del Minnesota dal 2014, ha effettuato la sua prima vendita per uso adulto il 16 settembre 2025, nel centro di Minneapolis.
Con una popolazione di 5,7 milioni di persone in Minnesota, Vireo prevede una forte crescita organica dei ricavi grazie a questa espansione di mercato. L'azienda offre una linea di prodotti completa che comprende fiori, pre-rotolati, edibili e bevande presso le sedi di Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester e Woodbury.
Vireo Growth (OTCQX: VREOF) ha lanzado ventas de cannabis para uso recreativo en los ocho dispensarios Green Goods® de Minnesota, marcando una expansión significativa respecto a sus operaciones médicas existentes. La empresa, que ha atendido al mercado médico de Minnesota desde 2014, realizó su primera venta para uso recreativo el 16 de septiembre de 2025 en el centro de Minneapolis.
Con una población de 5,7 millones de Minnesota, Vireo espera un fuerte crecimiento orgánico de ingresos gracias a esta expansión de mercado. La empresa ofrece una amplia gama de productos que incluye flores, pre-rolls, comestibles y bebidas en las ubicaciones de Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester y Woodbury.
Vireo Growth (OTCQX: VREOF)는 Minnesota의 8개 Green Goods® 매장에서 성인용 마리화나 판매를 시작하여 기존의 의약용 사업에서 Significant expansion를 이루었습니다. 2014년부터 Minnesota의 의약시장에 서비스를 제공해 온 이 회사는 2025년 9월 16일에 미니애폴리스 다운타운에서 첫 성인용 판매를 실시했습니다.
Minnesota의 인구 570만명을 가진 이 시장에서 Vireo는 이 확장을 통한 매출의 강한 유기적 성장을 기대합니다. 회사는 미니애폴리스, 블레인, 블루밍턴, 번스빌, 덜루스, 무어헤드, 로체스터, 우드베리의 매장에서 꽃, 프리롤, 식품(에디블), 음료 등 포괄적인 제품 라인을 제공합니다.
Vireo Growth (OTCQX: VREOF) a lancé la vente de cannabis récréatif dans les huit dispensaires Green Goods® du Minnesota, marquant une expansion significative par rapport à ses activités médicales actuelles. L'entreprise, qui dessert le marché médical du Minnesota depuis 2014, a réalisé sa première vente récréative le 16 septembre 2025, au centre-ville de Minneapolis.
Avec une population de 5,7 millions de personnes au Minnesota, Vireo prévoit une forte croissance organique de ses revenus grâce à cette expansion du marché. L'entreprise propose une gamme de produits complète comprenant des fleurs, des pré-rolls, des comestibles et des boissons dans les sites de Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester et Woodbury.
Vireo Growth (OTCQX: VREOF) hat den Verkauf von Cannabis für den Freizeitgebrauch in allen acht Green Goods®-Apotheken in Minnesota gestartet, was eine bedeutende Ausweitung der bisherigen medizinischen Geschäftstätigkeit darstellt. Das Unternehmen, das seit 2014 den medizinischen Markt von Minnesota bedient, realisierte seinen ersten Freizeitverkauf am 16. September 2025 im Zentrum von Minneapolis.
Bei einer Bevölkerung von 5,7 Millionen Menschen in Minnesota rechnet Vireo mit einem starken organischen Umsatzzuwachs durch diese Markterweiterung. Das Unternehmen bietet eine umfassende Produktpalette einschließlich Blumen, Pre-Rolls, essbare Produkte und Getränke in den Standorten Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester und Woodbury an.
Vireo Growth (OTCQX: VREOF) أطلق مبيعات القنب للاستخدام الشخصي في جميع متاجر Green Goods® الثمانية في ولاية مينيسوتا، وهو ما يمثل توسعاً هاماً عن عملياته الطبية القائمة. الشركة، التي تخدم سوق مينيسوتا الطبي منذ 2014، أجرت أول بيع للاستخدام الشخصي في 16 سبتمبر 2025، في وسط مدينة Minneapolis.
وبفضل عدد سكان 5.7 مليون في مينيسوتا، تتوقع Vireo نموًا قويًا في الإيرادات بشكل عضوي من هذا التوسع في السوق. تقدم الشركة مجموعة واسعة من المنتجات بما في ذلك الزهور، واللفائف المسبقة، والمواد القابلة للأكل، والمشروبات في مواقع في Minneapolis وBlaine وBloomington وBurnsville وDuluth وMoorhead وRochester وWoodbury.
Vireo Growth (OTCQX: VREOF) 已在明尼苏达州的全部八家 Green Goods® 药房推出面向成年人使用的大麻销售，将其现有的医疗大麻业务显著扩张。自2014年起为明尼苏达州的医疗市场服务的公司，于 2025年9月16日 在明尼阿波利斯市中心进行了首笔面向成年人使用的销售。
明尼苏达州的人口为 570万，Vireo 预计随着市场扩张将实现强劲的有机收入增长。该公司在明尼阿波利斯、布莱恩、布卢明顿、伯恩斯维尔、杜鲁斯、穆尔黑德、罗切斯特和伍德伯里等地的门店，提供花朵、预卷、食品及饮料等全面的产品线。
- Expansion into adult-use market while maintaining medical cannabis operations
- Established presence with 8 dispensary locations across Minnesota
- Large market opportunity with access to 5.7 million population
- 10+ years of operational experience in Minnesota's cannabis market
- Potential operational challenges in managing dual medical and recreational sales
- Increased competition expected in the expanding adult-use market
– Company now dispensing adult-use cannabis at all eight Green Goods® dispensaries in Minnesota –
– With a population of 5.7 million, adult-use launch expected to drive strong organic revenue growth –
MINNEAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF) today announced that on September 16, 2025, it recorded its first sale of adult use cannabis in Minnesota at its historic downtown Minneapolis Green Goods® dispensary. The Company is now dispensing a full suite of both medical and adult-use cannabis products at all eight of its Green Goods™ dispensaries located throughout the State of Minnesota.
Vireo has been operating in Minnesota’s medical cannabis market since 2014, serving tens of thousands of patients with safe, reliable products. The Company is committed to expanding access, improving product quality, and supporting the state’s transition to a sustainable, locally driven adult-use market. As one of the state’s operational licensed adult-use cannabis cultivators and retailers, and a population of 5.7 million people, the launch of Minnesota’s adult-use cannabis market is expected to serve as a strong organic revenue growth catalyst for Vireo for the foreseeable future.
Amber Shimpa, President of Vireo, commented, “As a Minnesota company founded with a long-term vision for cannabis, we are proud to begin making our products available to all Minnesotans. We will always remain committed to our medical patients and product portfolio as we have for over 10 years, and look forward to this new opportunity to serve adult-use customers with the same standard of quality and care.”
Alexandra Breant, Head of Market in Minnesota, commented, “This is a historic day for our team which we have been preparing for since 2023, and we are honored to share it with patients and new customers across Minnesota. This milestone is more than just expanding access, it’s about building community, fostering inclusion, and continuing to serve Minnesotans with care and responsibility. We are grateful for the trust placed in us and look forward to being part of this new chapter together.”
Green Goods® offers a full suite of medical and adult-use cannabis products and form factors including flower, pre-rolls, edibles, and beverages, and currently operates eight retail dispensaries in Minnesota. Green Goods® dispensaries are located in Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester, and Woodbury. For more information about Green Goods or to shop its product menu, please visit www.visitgreengoods.com.
About Vireo Growth Inc.
Vireo was founded in 2014 as a pioneering medical cannabis company. Vireo is building a disciplined, strategically aligned, and execution-focused platform in the industry. This strategy drives our intense local market focus while leveraging the strength of a national portfolio. We are committed to hiring industry leaders and deploying capital and talent where we believe it will drive the most value. Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it serves. For more information about Vireo, visit www.vireogrowth.com.
Contact Information
Amber Shimpa
President
ambershimpa@vireohealth.com
Joe Duxbury
Chief Accounting Officer
investor@vireogrowth.com
Forward-Looking Statement Disclosure
This press release contains “forward-looking information” within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes “financial outlooks” within the meaning of applicable United States or Canadian securities laws, this information is being provided as preliminary financial results; the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as “should,” “believe,” “estimate,” “would,” “looking forward,” “may,” “continue,” “expect,” “expected,” “will,” “likely,” “subject to,” and variations of such words and phrases, or any statements or clauses containing verbs in any future tense and includes statements regarding the Company’s future product portfolio and its plans related thereto and future growth opportunities for the Company. These statements should not be read as guarantees of future performance or results. Forward-looking information includes both known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company or its subsidiaries to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information contained in this press release. Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management’s experience and perception of trends, current conditions, and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, the reader should not place undue reliance on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to: risks related to the timing and content of adult-use legislation in markets where the Company currently operates; current and future market conditions, including the market price of the subordinate voting shares of the Company; risks related to epidemics and pandemics; federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws and regulations in the United States relating to cannabis operations in the United States and any changes to such laws or regulations; operational, regulatory and other risks; execution of business strategy; management of growth; difficulties inherent in forecasting future events; conflicts of interest; risks inherent in an agricultural business; risks inherent in a manufacturing business; liquidity and the ability of the Company to raise additional financing to continue as a going concern; the Company’s ability to meet the demand for flower in its various markets; risk of failure in the lawsuit with Verano and the cost of that litigation; our ability to dispose of our assets held for sale at an acceptable price or at all; and risk factors set out in the Company's Form 10-K for the year ended December 31, 2024, which is available on EDGAR with the U.S. Securities and Exchange Commission and filed with the Canadian securities regulators and available under the Company's profile on SEDAR+ at www.sedarplus.com.
The statements in this press release are made as of the date of this release. Except as required by law, we undertake no obligation to update any forward-looking statements or forward-looking information to reflect events or circumstances after the date of such statements.
FAQ
When did Vireo Growth (VREOF) begin adult-use cannabis sales in Minnesota?
How many dispensaries does Vireo operate in Minnesota?
What products does Vireo offer at its Minnesota dispensaries?
How long has Vireo been operating in Minnesota's cannabis market?
What is the market potential for Vireo in Minnesota's adult-use cannabis market?
